GL1X · GenesisL1 explorer

MolNFT v1 · #90613 · protein

Thr 160 phosphorylated CDK2 K89D, Q131E - human cyclin A3 complex with the inhibitor RO3306

4EOI · Cyclin-dependent kinase 2: “Thr 160 phosphorylated CDK2 K89D, Q131E - human cyclin A3 complex with the inhibitor RO3306”. X-ray diffraction, 1 ligand (1RO), 11 pockets (best druggability 0.81). MolNFT v1 #90613 on GenesisL1: 3D…

PDB
4EOI
Type
protein
Length
1,105 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cyclin-dependent kinase 2; Cyclin-A2
EC
2.7.11.22
UniProt
P24941, P20248
Ligands
1RO
Pockets
11 · best druggability 0.81

Structure

x-ray diffraction · 4 distinct chains · 49% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACyclin-dependent kinase 2 (EC 2.7.11.22)protein29536% helix, 17% strandP24941
BCyclin-A2protein25867% helix, 0% strandP20248
CCyclin-dependent kinase 2 (EC 2.7.11.22)protein29734% helix, 17% strandP24941
DCyclin-A2protein25565% helix, 0% strandP20248

Ligands and binding sites

  • 1RO · (5E)-5-(quinolin-6-ylmethylidene)-2-[(thiophen-2-ylmethyl)amino]-1,3-thiazol-4(5H)-one · ligand · 2 copies · chains A, C
  • SGM · Monothioglycerol · additive · 2 copies · chains A, B, D
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 10 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11170.810.9924empty
21140.800.9922empty
39920.770.7998empty
42130.720.88301RO
52150.690.86261RO

Interfaces

5 interfaces between chains.

  • C–D · 1638 Ų buried · 25 hydrogen bonds · protein-protein
  • A–B · 1623 Ų buried · 31 hydrogen bonds · protein-protein
  • B–C · 508 Ų buried · 4 hydrogen bonds · protein-protein
  • A–D · 488 Ų buried · 5 hydrogen bonds · protein-protein
  • A–C · 99 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 2 modified, 1 covalent (phosphorylation, additive adduct).

Compared structures

  • 4EOI · Thr 160 phosphorylated CDK2 K89D, Q131E - human cyclin A3 complex with the inhibitor… · the same entry in another collection · chain D against D, TM-score 1.00
  • P20248 · AlphaFold monomer V2.0 prediction for cyclin-A2 (P20248) · a predicted model of the same protein · chain B against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.